The influence of smoking on the clinical effects of a one-year program of physical rehabilitation of patients of working age who underwent acute myocardial infarction
- Authors: Bubnova M.G1, Aronov D.M1, Krasnitskii V.B1
-
Affiliations:
- National Medical Research Center for Preventive Medicine of the Ministry of Health of the Russian Federation
- Issue: Vol 8, No 2 (2017)
- Pages: 20-29
- Section: Articles
- URL: https://journals.rcsi.science/2221-7185/article/view/45306
- DOI: https://doi.org/10.26442/CS45306
- ID: 45306
Cite item
Full Text
Abstract
Full Text
##article.viewOnOriginalSite##About the authors
M. G Bubnova
National Medical Research Center for Preventive Medicine of the Ministry of Health of the Russian Federation
Email: mbubnova@gnicpm.ru
д-р мед. наук, проф., рук. отд. реабилитации и вторичной профилактики сочетанной патологии с лаб. профилактики атеросклероза и тромбоза ФГБУ НМИЦ ПМ 101990, Russian Federation, Moscow, Petroverigskii per., d. 10, str. 3
D. M Aronov
National Medical Research Center for Preventive Medicine of the Ministry of Health of the Russian Federationд-р мед. наук, проф., рук. лаб. кардиологической реабилитации ФГБУ НМИЦ ПМ, засл. деятель науки РФ 101990, Russian Federation, Moscow, Petroverigskii per., d. 10, str. 3
V. B Krasnitskii
National Medical Research Center for Preventive Medicine of the Ministry of Health of the Russian Federationканд. мед. наук, вед. науч. сотр. лаб. кардиологической реабилитации отд. реабилитации и вторичной профилактики сочетанной патологии ФГБУ НМИЦ ПМ 101990, Russian Federation, Moscow, Petroverigskii per., d. 10, str. 3
References
- Россия 2014. Стат. справочник. Р76 Росстат. М., 2014.
- Nichols M, Townsend N, Scarborough P, Rayner M. Cardiovascular disease in Europe: epidemiological update. Eur Heart J 2013; 34: 3028-34.
- Mathers C.D, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PloS Med 2011; 3: e442.
- Аронов Д.М., Красницкий В.Б., Бубнова М.Г. и др. Влияние физических тренировок на физическую работоспособность, гемодинамику, липиды крови, клиническое течение и прогноз у больных ишемической болезнью сердца после острых коронарных событий при комплексной реабилитации и вторичной профилактики на амбулаторно - поликлиническом этапе (Российское кооперативное исследование). Кардиология. 2009; 3: 49-56.
- Lawler P.R, Filion K.B, Eisenberg M.J. Efficacy of Exercise - Based Cardiac Rehabilitation Post-Myocardial Infarction: A Systematic Review and Meta - Analysis of Randomized Controlled Trials. Am Heart J 2011; 162: 571-84. http://dx.doi.org/10.1016/j.ahj.2011.07.017
- Jernberg T, Hasvold P, Henriksson M et al. Cardiovascular risk in post - myocardial infarction patients: nationwide real world data demonstrate the importance of a long - term perspective. Eur Heart J 2015; 36: 1163-70.
- Alnasser S.M, Huang W, Gore J.M et al. Late consequences of acute coronary syndromes: global registry of acute coronary events (GRACE) follow - up. Am J Med 2015; 128: 766-75.
- Марцевич С.Ю., Гинзбург М.Л., Кутишенко Н.П. и др. Люберецкое исследование смертности (исследование ЛИС): факторы, влияющие на отдаленный прогноз жизни после перенесенного инфаркта миокарда. Профилактическая медицина. 2013; 2: 32-8.
- González-Pacheco H, Vargas-Barrón J, Vallejo M et al. Prevalence of conventional risk factors and lipid profiles in patients with acute coronary syndrome and significant coronary disease. Ther Clin Risk Management 2014; 10: 815-23.
- Khot U.N, Khot M.B, Bajzer C.T et al. Prevalence of conventional risk factors in patients with coronary heart disease. JAMA 2003; 290 (7): 898-904.
- Weintraub W.S, Klein L.W, Seelaus P.A et al. Importance of total life consumftion of cigarettes as a risk factor for coronary artery disease. Am J Cardiol 1985; 55: 669-72.
- Waters D, Lesperance J, Gladstone P et al. Effects of cigarette smoking on the angiographic evolution of coronary atherosclerosis: a Canadian Coronary Atherosclerosis Intervention Trial (CCAIT) Substudy. Circulation 1996; 94: 614-21.
- Hasdai D, Garratt K.N, Grill D.E et al. Effect of smoking status on the long - term outcome after successful percutaneous coronary revascularization. N Engl J Med 1997; 336: 755-61.
- Gambardella J, Sardu C, Sacra C, Santulli G. Quit smoking to outsmart atherogenesis: Molecular mechanisms underlying clinical evidence. Atherosclerosis 2017; 257: 242-5. http://dx.doi.org/10.1016/j.atherosclerosis.2016.12.010
- Красницкий В.Б., Аронов Д.М., Джанхотов С.О. Изучение физической активности у больных ИБС с помощью специализированного Опросника Двигательной Активности «ОДА-23+». Кардиоваскулярная терапия и профилактика. 2011; 8: 90-7.
- Гладков А.Г., Зайцев В.П., Аронов Д.М., Шарфнадель М.Г. Оценка качества жизни больных с сердечно - сосудистыми заболеваниями. Кардиология. 1982; 2: 100-3.
- Zieske A.W, Takei H, Fallon K.B, Strong J.P. Smoking and atherosclerosis in youth. Atherosclerosis 1999; 144: 403-8.
- Csordas A, Bernhard D. The biology behind the atherothrombotic effects of cigarette smoke. Nat Rev Cardiol 2013; 10: 219-30.
- Ambrose J.A, Barua R.S. The pathophysiology of cigarette smoking and cardiovascular disease: an update. J Am Coll Cardiol 2004; 43: 1731-7.
- Аронов Д.М. Современные представления о влиянии курения на сердечно - сосудистую систему. Тер. архив. 1978; 4: 117-26.
- Barreiro E, del Puerto-Nevado L, Puig-Vilanova E et al. Cigarette smoke - induced oxidative stress in skeletal muscles of mice. Respir Physiol Neurobiol 2012; 182 (1): 9-17.
- Liu Q, Xu W.G, Luo Y et al. Cigarette smoke - induced skeletal muscle atrophy is associated with up - regulation of USP-19 via p38 and ERK MAPKs. J Cell Biochem 2011; 112 (9): 2307-16.
- Rinaldi M, Maes K, de Vleeschauwer S et al. Long - term nose - only cigarette smoke exposure induces emphysema and mild skeletal muscle dysfunction in mice. Dis Model Mech 2012; 5 (3): 333-41.
- Rivers J.T, White H.D, Cross D.B. Reinfarction after thrombolytic therapy for acute myocardial infarction followed by conservative managemint: incident and effect of smoking. J Am Coll Cardiol 1990; 16: 340-8.
- Аронов Д.М., Бубнова М.Г., Барбараш О.Л. и др. Российские клинические рекомендации «Острый инфаркт миокарда с подъемом сегмента ST на ЭКГ: реабилитация и вторичная профилактика» (2014 г., по поручению Минздрава России, утверждены профессиональными сообществами). CardioСоматика. 2014; с. 4-42.
- Frey P, Waters D.D, De Micco D.A. Impact of smoking on cardiovascular events in patients with coronary disease receiving contemporary medical therapy (from the Treating to New Targets [TNT] and the Incremental Decrease in End Points through Aggressive Lipid Lowering [IDEAL] trials). Am J Cardiol 2011; 107: 145-50.
- Sturchio A, Gianni A.D, Campana B et al. Coronary Artery RIsk MAnagement Programme (CARIMAP) Delivered by a Rehabilitation Day - Hospital. J Cardiopulmonary Rehabilitation Prevention 2012; 32: 386-93.
- Prugger Ch, Wellmann J, Heidrich J et al. on behalf of the EUROASPIRE Study Group. Passive smoking and smoking cessation among Patients with coronary heart disease across Europe: results from the EUROASPIRE III survey. Eur Heart J 2014; 35: 590-8. doi: 10.1093/eurheartj/eht538.
- Bustamante M.J, Valentino G, Krämer V et al. Patient Adherence to a Cardiovascular Rehabilitation Program: What Factors Are Involved? Int J Clin Med 2015; 6: 605-14.
- Бубнова М.Г., Аронов Д.М., Оганов Р.Г. и др. (от имени исследователей). Клиническая характеристика и общие подходы к лечению пациентов со стабильной стенокардией в реальной практике. Российское исследование «ПЕРСПЕКТИВА» (часть I). Кардиоваскулярная терапия и профилактика. 2010; 6: 47-56.
- Piepoli M.F, Hoes A.W, Agewall S et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J 2016; 37: 2315-81 doi: 10.1093/eurheartj/ehw106.
- Бокерия Л.А., Аронов Д.М., Барбараш О.Л. и др. Российские клинические рекомендации. Коронарное шунтирование больных ишемической болезнью сердца: реабилитация и вторичная профилактика // CardioСоматика. 2016; 3-4: 5-71.
- Cahill K, Stevens S, Perera R, Lancaster T. Pharmacological interventions for smoking cessation: an overview and network meta - analysis. Cochrane Database of Systematic Reviews. The Cochrane Collaboration and published in The Cochrane Library 2013, Issue 5: CD009329.doi: 10.1002/14651858.CD009329.pub2.
- Vadasz I. The first Hungarian experiences with varenicline to support smoking cessation. Medicina Thoracalis 2009; LXII. 1: 1-9.
- Anthenelli R.M, Benowitz N.L, West R et al. Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double - blind, randomised, placebo - controlled clinical trial. Lancet 2016; 387: 2507-20.
- Eisenberg M.J, Windle S.B, Roy N et al. Varenicline for Smoking Cessation in Hospitalized Patients With Acute Coronary Syndrome. Circulation 2015. doi: 10.1161/CIRCULATIONAHA.115. 019634.
- Rigotti N.A, Pipe A.L, Benowitzm N.L et al. Efficacy and safety of varenicline for smoking cessation in patients with cardiovascular disease: a randomized trial. Circulation 2010; 121: 221-9.
- Prochaska J.J, Hilton J.F. Risk of cardiovascular serious adverse events associated with varenicline use for tobacco cessation: systematic review and meta - analysis. BMJ 2012; 344: e2856. doi: 10.1136/bmj.e2856.